Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug
Shares fall 11% following two patient deaths in trials of lecanemab
Full Article
Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug
FT.com
0 shares
1 views